Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy W Kinlock

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Addiction (Abingdon, England)|February 28, 2017
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorderSean M Murphy, Daniel Polsky, Joshua D Lee, et al.
Contemporary Clinical Trials|January 21, 2015
Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trialJoshua D Lee, Peter D Friedmann, Tamara Y Boney, et al.
Substance Abuse|January 24, 2012
A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationersDonna M Coviello, James W Cornish, Kevin G Lynch, et al.
The New England Journal of Medicine|March 31, 2016
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice OffendersJoshua D Lee, Peter D Friedmann, Timothy W Kinlock, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Addiction (Abingdon, England)|February 28, 2017
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorderSean M Murphy, Daniel Polsky, Joshua D Lee, et al.
Contemporary Clinical Trials|January 21, 2015
Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trialJoshua D Lee, Peter D Friedmann, Tamara Y Boney, et al.
Substance Abuse|January 24, 2012
A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationersDonna M Coviello, James W Cornish, Kevin G Lynch, et al.
The New England Journal of Medicine|March 31, 2016
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice OffendersJoshua D Lee, Peter D Friedmann, Timothy W Kinlock, et al.
Pageof 4